GlaxoSmithKline's New Sales Force Compensation System in the US
|
|
ICMR HOME | Case Studies Collection
To download GlaxoSmithKline's New Sales Force Compensation System in the US case study
(Case Code: MKTG258) click on the button below, and select the case from the list of available cases:
» Marketing Case Studies
» Marketing Management Short Case Studies
» View Detailed Pricing Info » How To Order This Case
» Business Case Studies
» Case Studies by Area
» Case Studies by Industry
» Case Studies by Company
Please note:
This case study was compiled from published sources, and is intended to be used as a basis for class discussion. It is not intended to illustrate either effective or ineffective handling of a management situation. Nor is it a primary information source.
Chat with us
Please leave your feedback
|
Case Details:
|
Price: |
Case Code |
: |
MKTG258 |
For delivery in electronic format:
Rs. 400;
For delivery through courier (within India): Rs. 400 + Shipping & Handling Charges extraThemes
Product Design
|
Case Length |
: |
10 Pages |
Period |
: |
2009-2010 |
Pub Date |
: |
2010 |
Teaching Note |
: |
Not Available |
Organization |
: |
GlaxoSmithKline Plc |
Industry |
: |
Pharmaceutical |
Countries |
: |
US |
Abstract:
In July 2010, GlaxoSmithKline Plc (GSK), one of the world's leading pharmaceutical companies, announced that it would replace its existing system of evaluating and compensating its sales professionals in the US.
As part of the new system, the bonuses of the sales professionals would be based on customer feedback and adherence to company policy rather than the widely used practice of focusing on individual achievement of sales targets. Industry observers viewed GSK's new sales force compensation plan as a radical change and their opinion was divided regarding the effectiveness of the new sales force compensation system.
|
|
Issues:
» To understand the various issues and challenges associated with evaluating and compensating a sales force.
» To understand the pharma selling environment in the US.
» To analyze the new sales force compensation system of GSK in the US and discuss the pros and cons of the system.
» Explore ways in which the system can be improved further.
Contents:
Keywords:
Sales Force Compensation, Sales Force Evaluation, Sales compensation system, Pharma selling environment, Sales productivity, Sales force profitability, Base salaries, Bonuses, Incentives, Reward, Overtime pay, Sales targets, Transactional product-focused model, Dialogue focused model, The Fair Labor Standards Act (FLSA), GlaxoSmithKline
GlaxoSmithKline's New Sales Force Compensation System in the US
- Next Page>>
|
|